Effects of Exenatide Plus Rosiglitazone on β-Cell Function and Insulin Sensitivity in Subjects With Type 2 Diabetes on Metformin

OBJECTIVE: Study the effects of exenatide (EXE) plus rosiglitazone (ROSI) on β-cell function and insulin sensitivity using hyperglycemic and euglycemic insulin clamp techniques in participants with type 2 diabetes on metformin. RESEARCH DESIGN AND METHODS: In this 20-week, randomized, open-label, mu...

Descripción completa

Detalles Bibliográficos
Autores principales: DeFronzo, Ralph A., Triplitt, Curtis, Qu, Yongming, Lewis, Michelle S., Maggs, David, Glass, Leonard C.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858197/
https://www.ncbi.nlm.nih.gov/pubmed/20107105
http://dx.doi.org/10.2337/dc09-1521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858197/
https://www.ncbi.nlm.nih.gov/pubmed/20107105
http://dx.doi.org/10.2337/dc09-1521

Ejemplares similares